Sanjeev Balu, PhD

Senior Director, US Medical Affairs, Health Economics & Outcomes Research (HEOR)
LEO Pharma Inc.

Poster(s):

• (105) Economic burden of moderate-to-severe chronic hand eczema in the United States: A retrospective claims analysis
  Wednesday, October 29, 2025

• (106) Budget impact analysis of tralokinumab-ldrm for moderate-to-severe atopic dermatitis in the United States
  Wednesday, October 29, 2025